Skip to Content

Notice

Importer of Controlled Substances; Notice of Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated June 17, 2010, and published in the Federal Register on June 28, 2010, 75 FR 36680, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances:

DrugSchedule
Cathinone (1235)I
Methaqualone (2565)I
Lysergic acid diethylamide (7315)I
Marihuana (7360)I
Tetrahydrocannabinols (7370)I
4-Methyl-2,5-dimethoxyamphetamine (7395)I
3,4-Methylenedioxyamphetamine (7400)I
Codeine-n-oxide (9053)I
Heroin (9200)I
Amphetamine (1100)II
DrugSchedule
Methamphetamine (1105)II
Phenmetrazine (1631)II
Methylphenidate (1724)II
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
Glutethimide (2550)II
Phencyclidine (7471)II
Alphaprodine (9010)II
Anileridine (9020)II
Cocaine (9041)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Diphenoxylate (9170)II
Hydrocodone (9193)II
Levorphanol (9220)II
Meperidine (9230)II
Methadone (9250)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
DrugSchedule
Morphine (9300)II
Thebaine (9333)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Alfentanil (9737)II
Sufentanil (9740)II

The company plans to import reference standards for sale to researchers and analytical labs.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of United States Pharmacopeial Convention to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated United States Pharmacopeial Convention to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.

Start Signature

Dated: December 23, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2011-12 Filed 1-5-11; 8:45 am]

BILLING CODE 4410-09-P